AMRX Operating Income Growth
Amneal Pharmaceuticals Inc Class A · Operating Income Growth
AMRX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported7.15%period ending
AMRX TTM Operating Income YoY % (-86.04% → 7.15%)
Year-over-year change
High-resolution chart · PNG
AMRX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 7.1519% | |
| 2.2773% | |
| 30.7942% | |
| 53.0928% | |
| 115.5764% | |
| 126.4237% | |
| 21.995% | |
| -17.0136% | |
| -10.4418% | |
| 289.9873% | |
| 315.2937% | |
| 288.8492% | |
| 243.7205% | |
| -164.3928% | |
| -162.1598% | |
| -174.0698% | |
| -199.9882% | |
| 64.1382% | |
| 67.5344% | |
| 238.0273% | |
| 302.8489% | |
| 182.1197% | |
| 136.6552% | |
| 123.6529% | |
| -333.1325% | |
| 45.643% | |
| -1,164.0777% | |
| -660.8246% | |
| -138.3419% | |
| -166.7799% | |
| -108.0264% | |
| -86.0415% |